Downloadable Slidesets

Share

Program Content

Activities

  • Melanoma Tx Overview
    NED TALK: Overview of Current Treatment Algorithms, Evidence-Based Review of Available Adjuvant and Neoadjuvant Therapy Options, and Importance of Engaging the Patient/Caregiver to Partner in Care
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 31, 2022

    Expires: January 30, 2023

  • Melanoma: irAE Mngt
    NED TALK: Management of Adverse Events With Immune Checkpoint Inhibitors for Metastatic Melanoma
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 31, 2022

    Expires: January 30, 2023

  • TRAEs: Best Practices
    Expert Panel Discussion 1: Best Practices to Proactively Address Treatment-Related AEs
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 31, 2022

    Expires: January 30, 2023

  • Melanoma Actionable Mut
    Caring for Patients With Melanoma and Actionable Mutations
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 31, 2022

    Expires: January 30, 2023

  • Target Therapy AEs Mngt
    Expert Panel Discussion 2: Targeted Therapy Adverse Event Management
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 31, 2022

    Expires: January 30, 2023

Faculty

cover img faculity

Kathleen Madden, FNP, MSN, AOCNP, APHN

Melanoma Program
NYU Langone Perlmutter Cancer Center
New York, NY

cover img faculity

Suzanne McGettigan, MSN, AOCN, ANP-BC

Nurse Practitioner, Clinical Manager
Division of Hematology-Oncology
Abramson Cancer Center
Penn Medicine
University of Pennsylvania
Philadelphia, Pennsylvania

cover img faculity

Krista M. Rubin, MS, RN, FNP-BC

Nurse Practitioner
Center for Melanoma
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

Merck Sharp & Dohme Corp.

Novartis Pharmaceuticals Corporation